ECG Devices Market is to Touch $13.2 Billion by 2031; The rising prevalence of cardiovascular diseases

The ECG Devices Market size is estimated to reach $13.2 Billion by 2031, growing at a CAGR of 7.3% during the forecast period 2025-2031, according to a recent report published by IndustryARC, titled, “ECG Devices Market – By (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Advanced ECG Devices and Others), By Technology (Analog and Digital), By Number of Leads (1 channel, 3 channels, 6 channels, 12 channels), By Portability (Stationary and Portable) By Application (Cardiovascular Diseases Diagnosis, Arrhythmia Detection and Others), By End Use Industry (Hospitals, Speciality Clinics, Ambulatory Surgical Centres and Others) and By Geography - Opportunity Analysis & Industry Forecast, 2025-2031.”

 

The key drivers of the ECG Devices market include the rising prevalence of cardiovascular diseases, growing awareness about early disease detection, advancements in ECG technology, expanding healthcare infrastructure in emerging economies, and increasing adoption of portable and wireless ECG devices.

 

 

North America dominates the ECG Devices market, accounting for approximately 46% of the share in 2024. North America has a growing population, which is at a higher risk of developing cardiovascular diseases such as heart attack, stroke, and heart failure. For instance, according to Centers for Disease Control and Prevention (CDC), In the United States heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups. One person dies every 33 seconds from cardiovascular disease. Every year, about 8,05,000 people in the United States have a heart attack. Of these, 605,000 are a first heart attack, and 200,000 happen to be people who have already had a heart attack. About 1 in 5 heart attacks are silent - the damage is done, but the person is not aware of it.

 

 

 

The demand for portable and wearable ECG devices is rapidly growing due to the rising prevalence of cardiovascular diseases and the increasing need for continuous monitoring. As healthcare trends shift towards home-based care and preventive health management, these devices offer an accessible and cost-effective solution for patients to track their heart health outside of traditional medical settings. Key innovations in this segment include the integration of wearable ECG monitors with smartphones and mobile apps, enabling real-time heart data analysis and early detection of abnormalities. Additionally, advancements in AI algorithms for ECG interpretation further enhance the accuracy of diagnoses. The popularity of such devices is particularly high in regions like APAC and North America, driven by increasing telemedicine adoption and growing health awareness. In June 2024, AliveCor’s FDA-cleared Kardia 12L ECG System is a handheld 12-lead device designed for professional use, complemented by KAI 12L software capable of detecting 35 heart conditions. Compact and user-friendly, it aims to provide ECG access in settings without traditional machines, accelerating decisions for critical cases like heart attacks.

 

 

 

Integrating ECG systems with telemedicine platforms allows healthcare providers to monitor patients’ heart health in real time, especially in rural or underserved areas with limited healthcare access. Remote monitoring enables continuous tracking of ECG data, facilitating timely interventions and personalized treatment plans without requiring frequent hospital visits. The COVID-19 pandemic accelerated the adoption of telehealth, increasing the demand for cloud-based ECG systems that support data sharing and remote analysis. These innovations empower healthcare professionals to diagnose and manage heart conditions efficiently, improving patient outcomes and expanding the reach of cardiac care to a broader population. In May 2024, Omron Healthcare India and AliveCor India partnered to market AI-powered handheld ECG and Afib monitoring devices in India. This collaboration expands Omron's focus from hypertension to cardiovascular health, introducing devices like a home blood pressure monitor with ECG capability and compact personal ECG Devices. 

 

 

• In January 2025, OMRON Healthcare India has partnered with AliveCor India to offer AI-based handheld ECG technology alongside its blood pressure monitors. The collaboration introduces FDA-cleared devices for early cardiovascular disease detection, including the OMRON COMPLETE, which combines ECG and blood pressure monitoring in one unit.
• In Octorber 2024, Wellvii Inc. and B-Secur partnered to launch BP Go Rhythm, a compact device combining finger-based blood pressure and single-lead ECG monitoring. With Bluetooth and cellular IoT connectivity, it offers portability, comfort, and seamless data sharing for home and remote patient care. 

 

 

Key companies profiled in the ECG Devices Market are Philips Healthcare, GE Healthcare, Mindray Medical International Ltd, Baxter, Nihon Kohden Corporation, Schiler AG, BPL Medical Technologies Private Limited, Stryker Corporation, Edan Instruments, AliveCor and others.

 

 

Cardiovascular Monitoring & Diagnostic Devices Market - Cardiovascular Monitoring & Diagnostic Devices Market size is estimated to reach $3.7 billion by 2026, growing at a CAGR of 7.4% during the forecast period 2021-2026. The market is being driven by an increasing number of people suffering from obesity and diabetes. Risk factors including high blood pressure and high cholesterol are associated with obesity and diabetes leads to cardiovascular diseases, which is enhancing the market growth.

 

Electrocardiograph Market -Electrocardiograph Market size in 2020 was estimated at $5.1 billion, growing at a CAGR of 5.8% during the forecast period 2021-2026. Rising prevalence of cardiovascular diseases such as heart attack, coronary artery diseases coupled with rising aging population is major factor driving the growth of the market.

 

Electrophysiology Devices Market – Electrophysiology Market size is forecast to reach $25043 billion by 2030, after growing at a CAGR of 13.90% during 2024-2030. Globally, technological advancement in healthcare services and an increasing population with cardiac diseases as a result of life style are expected to be the key growth drivers during the period of study.

 

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.  

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.

Contact Us:

Mr. Venkat Reddy

IndustryARC

Email: [email protected]

USA: (+1) 518-282-4727